Nasdaq
$3.48▲ 0.58%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $572.9MShares out 1.600M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
9- 10.16Pre-market26.10.16 20:308-KKey event#●●●
IRONWOOD PHARMACEUTICALS INC
Ironwood Pharmaceuticals has appointed Chief Commercial Officer Tammi Gaskins as the new CEO, effective January 1, 2027. Current CEO Thomas McCourt will retire on December 31, 2026, and will continue to serve on the Board of Directors.…more
$3.48+0.58%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.23After-hours26.09.24 05:08144Ownership
IRONWOOD PHARMACEUTICALS INC
Michael Shetzline, an executive at Ironwood Pharmaceuticals, has filed a Form 144 to report the proposed sale of company securities. This filing serves as a formal notification of the insider's plan to dispose of shares.…more
$3.48+0.58%vs prev closeView filingShare - 9.17After-hours26.09.18 05:054Ownership
IRONWOOD PHARMACEUTICALS INC
Insider Alexander J. Denner of Ironwood Pharmaceuticals (IRWD) filed a Form 4 report regarding changes in beneficial ownership of securities as of September 15, 2026. This filing serves as an official disclosure of insider stock transactions.…more
$3.48+0.58%vs prev closeView filingShare
8 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.16Pre-market26.10.16 20:32#●●●
Ironwood Pharmaceuticals Appoints Tammi Gaskins as CEO Effective Jan 2027…more
Ironwood Pharmaceuticals announced that current Chief Commercial Officer Tammi Gaskins will become the new CEO on January 1, 2027. Current CEO Tom McCourt will retire from his position but will continue to serve on the Board of Directors.…more
$3.48+0.58%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga